Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

McGill University

$72,000.00

Genetic Regulation of Natural Killer cell Homeostasis and Function

FY 2023-24

Summary
Natural Killer (NK) cells are a population of cytotoxic innate lymphocytes with a crucial role in protection against tumors and virus infections. Studies of rare patients and mouse mutants with germ line mutations leading to NK cell deficiencies have illuminated fundamental mechanisms of NK cell development and function. It is notable that certain NK cell depleting mutations impact on cell mechanisms present in every cell such as DNA replication or ribosome assembly. The latter are known as ribosomopathies, which are genetic diseases caused by mutation in ribosome structural proteins or maturation factors. Ribosomopathies show characteristically tissue specific effects, in part due to the p53-mediated cell-death pathway that can be activated by free ribosomal proteins. This discovery grant will confront the issue of why NK cells appear to be more susceptible than other lymphocytes to defects in ribosomes hoping to illuminate new molecular determinants of NK cell development and homeostatic requirements. In a recent genome-wide chemical (ENU) screen for altered response to mouse cytomegalovirus (MCMV)infection, we have identified a pedigree showing severe susceptibility to MCMV due to NK cell-specific deficiency. A recessive stop-gain mutation (C567X) in the translational GTPase guanine nucleotide binding protein-like 1 (Gnl1) gene dictated an NK cell-specific phenotype characterized by 1) lack of homeostatic proliferation and decreased cell survival in vivo; 2) blockade of cell cycle in response to the homeostatic cytokine IL-15 ex vivo; 3) inflammatory proliferation during MCMV infection. GNL1 is predicted to encode a ribosome assembly factor the dysfunction of which results in p53-dependent cell death. Characterization of the immune compartment in p53 and Gnl1 doubly-deficient mice showed a full rescue of Gnl1(C367X) deficits in NK cell numbers and survival. Based on these results we hypothesized that p53 activation is a driving mechanism for NK cell abnormalities in homeostasis and survival in Gnl1-deficient mice. To test this hypothesis, we propose a multipronged approach involving 1) the use of bone marrow chimera mice, and adoptive transfer of cell sorted cell populations, to determine the immunological compartments affected by Gnl1 deficiency; 2) the identification of transcriptional networks disrupted in Gnl1(C367X) NK cells by examining cytosolic and polysome-associated transcripts, using RNA sequencing; 3) the screening and validating GNL1 binding partners to ultimately situate GNL1 in a biochemical pathway. This research program will further our understanding of NK cell development and homeostasis while producing cutting-edge results about tissue-specific functions of ribosome-associated proteins. The proposal will enable a graduate student and a post-doctoral fellow to learn advanced immunological, genomic and biochemical techniques, thus providing an ideal setting for training of highly qualified personnel.
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2019-06457
Name nom
Vidal, Silvia
Department département
Human Genetics
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2019
Award amount
72000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
5100
Research subject group en
Cell biology
Research subject group fr
Cell biology
Research subject en
Biologie cellulaire
Research subject fr
Biologie cellulaire
Application title
Genetic Regulation of Natural Killer cell Homeostasis and Function
Keyword
BIO-ID; flow cytometry; Mouse genetic models; Natural killer cells; p53; RNAsequencing; translational GTPases
Application summary
Natural Killer (NK) cells are a population of cytotoxic innate lymphocytes with a crucial role in protection against tumors and virus infections. Studies of rare patients and mouse mutants with germ line mutations leading to NK cell deficiencies have illuminated fundamental mechanisms of NK cell development and function. It is notable that certain NK cell depleting mutations impact on cell mechanisms present in every cell such as DNA replication or ribosome assembly. The latter are known as ribosomopathies, which are genetic diseases caused by mutation in ribosome structural proteins or maturation factors. Ribosomopathies show characteristically tissue specific effects, in part due to the p53-mediated cell-death pathway that can be activated by free ribosomal proteins. This discovery grant will confront the issue of why NK cells appear to be more susceptible than other lymphocytes to defects in ribosomes hoping to illuminate new molecular determinants of NK cell development and homeostatic requirements. In a recent genome-wide chemical (ENU) screen for altered response to mouse cytomegalovirus (MCMV)infection, we have identified a pedigree showing severe susceptibility to MCMV due to NK cell-specific deficiency. A recessive stop-gain mutation (C567X) in the translational GTPase guanine nucleotide binding protein-like 1 (Gnl1) gene dictated an NK cell-specific phenotype characterized by 1) lack of homeostatic proliferation and decreased cell survival in vivo; 2) blockade of cell cycle in response to the homeostatic cytokine IL-15 ex vivo; 3) inflammatory proliferation during MCMV infection. GNL1 is predicted to encode a ribosome assembly factor the dysfunction of which results in p53-dependent cell death. Characterization of the immune compartment in p53 and Gnl1 doubly-deficient mice showed a full rescue of Gnl1(C367X) deficits in NK cell numbers and survival. Based on these results we hypothesized that p53 activation is a driving mechanism for NK cell abnormalities in homeostasis and survival in Gnl1-deficient mice. To test this hypothesis, we propose a multipronged approach involving 1) the use of bone marrow chimera mice, and adoptive transfer of cell sorted cell populations, to determine the immunological compartments affected by Gnl1 deficiency; 2) the identification of transcriptional networks disrupted in Gnl1(C367X) NK cells by examining cytosolic and polysome-associated transcripts, using RNA sequencing; 3) the screening and validating GNL1 binding partners to ultimately situate GNL1 in a biochemical pathway. This research program will further our understanding of NK cell development and homeostasis while producing cutting-edge results about tissue-specific functions of ribosome-associated proteins. The proposal will enable a graduate student and a post-doctoral fellow to learn advanced immunological, genomic and biochemical techniques, thus providing an ideal setting for training of highly qualified personnel.